I-MAB SPONS.ADS/1 -0001 Total Liabilities

Latest as of December 2025: €29.58 Million EUR ≈ $34.58 Million USD

I-MAB SPONS.ADS/1 -0001 total liabilities. Based on the latest financial reports, I-MAB SPONS.ADS/1 -0001 (0VY) has total liabilities worth €29.58 Million EUR (≈ $34.58 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check I-MAB SPONS.ADS/1 -0001 liquid asset ratio to evaluate the company's liquid asset resilience ratio.

Total Liabilities of I-MAB SPONS.ADS/1 -0001 (2021–2025)

Total liabilities of I-MAB SPONS.ADS/1 -0001 from 2021 to 2025. This chart illustrates how I-MAB SPONS.ADS/1 -0001's total liabilities have evolved over time, based on quarterly financial data. Explore 0VY strategic capital deployment ratio to see how much of total assets are deployed in long-term investments.

I-MAB SPONS.ADS/1 -0001 Competitors by Total Liabilities

The table below lists competitors of I-MAB SPONS.ADS/1 -0001 ranked by their total liabilities.

Company	Country	Total Liabilities
AIRO Group Holdings, Inc. Common Stock NASDAQ:AIRO	USA	$35.03 Million
Forth Smart Service Public Company Limited BK:FSMART	Thailand	฿1.94 Billion
Pantech Group Holdings Bhd KLSE:5125	Malaysia	RM349.18 Million
Seoul Broadcasting System KO:034120	Korea	₩648.38 Billion
Userjoy Technology Co Ltd TWO:3546	Taiwan	NT$885.37 Million
Warehouses Estates Belgium SCA BR:WEB	Belgium	€160.60 Million
Cystech Electronics Corp TWO:6651	Taiwan	NT$352.87 Million

Liability Composition Analysis (2021–2025)

This chart breaks down I-MAB SPONS.ADS/1 -0001's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see I-MAB SPONS.ADS/1 -0001 (0VY) total assets.

Liquidity & Leverage Metrics

I-MAB SPONS.ADS/1 -0001 Total Liabilities Ratios Explained

I-MAB SPONS.ADS/1 -0001 total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	8.09	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.13	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.11	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how I-MAB SPONS.ADS/1 -0001's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for I-MAB SPONS.ADS/1 -0001 (2021–2025)

The table below shows the annual total liabilities of I-MAB SPONS.ADS/1 -0001 from 2021 to 2025.

Year	Total Liabilities	Change
2025-12-31	€29.58 Million ≈ $34.58 Million	+156.78%
2024-12-31	€11.52 Million ≈ $13.47 Million	-90.88%
2023-12-31	€126.34 Million ≈ $147.70 Million	-25.10%
2022-12-31	€168.68 Million ≈ $197.20 Million	+3.22%
2021-12-31	€163.42 Million ≈ $191.05 Million	--

About I-MAB SPONS.ADS/1 -0001

F:0VY Germany Biotechnology

Market Cap

$141.97 Million

€121.43 Million EUR

Market Cap Rank

#17690 Global

#1658 in Germany

Share Price

€1.05

Change (1 day)

-1.87%

52-Week Range

€1.05 - €4.46

All Time High

€70.00